SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $64,000 | -91.6% | 65 | -91.7% | 0.01% | -90.4% |
| Q1 2022 | $766,000 | -96.0% | 784 | -96.0% | 0.05% | -97.7% |
| Q2 2021 | $19,107,000 | 0.0% | 19,638 | 0.0% | 2.29% | 0.0% |
| Q1 2021 | $19,107,000 | +70.4% | 19,638 | +69.6% | 2.29% | +253.0% |
| Q4 2020 | $11,212,000 | -83.0% | 11,578 | -83.7% | 0.65% | -91.1% |
| Q3 2020 | $66,106,000 | +12.0% | 71,073 | +7.3% | 7.33% | +3.4% |
| Q2 2020 | $59,011,000 | +34.8% | 66,249 | +23.6% | 7.09% | +37.6% |
| Q1 2020 | $43,776,000 | -32.7% | 53,600 | -24.8% | 5.15% | -1.3% |
| Q4 2019 | $65,085,000 | -11.1% | 71,238 | -9.1% | 5.22% | +9.1% |
| Q3 2019 | $73,175,000 | +4.8% | 78,382 | +10.1% | 4.78% | +1.4% |
| Q2 2019 | $69,799,000 | – | 71,162 | – | 4.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|